Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Driver Mutation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07062172
What this trial is testing

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Who this might be right for
Lung CancerDriver Mutation
University of California, Irvine 1,753
Testing effectiveness (Phase 2)Study completedNCT04144582
What this trial is testing

Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Yongchang Zhang 30
Not applicableStudy completedNCT06331975
What this trial is testing

Radiomics and Radiogenomics of Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
European Institute of Oncology 91
Testing effectiveness (Phase 2)Ended earlyNCT02949843
What this trial is testing

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Who this might be right for
EGFR Activating MutationRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Study completedNCT01922583
What this trial is testing

AUY922 in Patient With Stage IV NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
National Taiwan University Hospital 31
Not applicableActive Not RecruitingNCT06443684
What this trial is testing

Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Chest Hospital 305
Testing effectiveness (Phase 2)Active Not RecruitingNCT04053322
What this trial is testing

Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

Who this might be right for
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancera Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
UNICANCER 172
Not applicableLooking for participantsNCT05378204
What this trial is testing

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
Institut Claudius Regaud 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06955325
What this trial is testing

Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations

Who this might be right for
Non-Small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 270
Post-approval studies (Phase 4)Study completedNCT04659915
What this trial is testing

Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin

Who this might be right for
Glucocorticoid Effect
Eleonora Seelig 19
Testing effectiveness (Phase 2)Study completedNCT02889900
What this trial is testing

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
AstraZeneca 62
Not applicableUnknownNCT05769166
What this trial is testing

Prevalence Of Deleterious Oral Habits Among a Group of School Children in Cairo, Egypt: Cross-Sectional Study

Who this might be right for
HabitsBruxismSucking Behavior+1 more
Ahram Canadian University 1,500
Testing effectiveness (Phase 2)Study completedNCT01989546
What this trial is testing

Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations

Who this might be right for
Advanced Ovarian CancerPrimary Peritoneal CancerAdvanced Breast Cancer+1 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Looking for participantsNCT07444437
What this trial is testing

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Suzhou BlueHorse Therapeutics Co., Ltd. 45
Very early researchWithdrawnNCT02277457
What this trial is testing

Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations

Who this might be right for
Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center
Not applicableStudy completedNCT05120869
What this trial is testing

Healthcare Provider Human Papillomavirus Education and Professional Skills Intervention

Who this might be right for
Health Personnel AttitudeHealth Knowledge, Attitudes, Practice
University of Texas, El Paso 161
Not applicableStudy completedNCT03267641
What this trial is testing

Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 86
Not applicableStudy completedNCT02982408
What this trial is testing

Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsulin ResistanceDyslipidemia
Rigshospitalet, Denmark 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06299371
What this trial is testing

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Who this might be right for
Non Small Cell Lung Cancer
Liaoning Cancer Hospital & Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT05800340
What this trial is testing

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Who this might be right for
Non-Small Cell Lung CancerRET Driver MutationBRAF V600 Mutation+3 more
Guangdong Provincial People's Hospital 30
Next Page